All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| SPRB / Spruce Biosciences, Inc.
|
|
|
|
|
|
|
|
| NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
| LIAN / LianBio - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GERN / Geron Corporation
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MOR / MorphoSys AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIGL / Vigil Neuroscience, Inc.
|
|
|
|
|
|
|
|
| MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
| ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DICE / DICE Therapeutics Inc
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
